Menu Close
The Conversation

Articles on Mammogram

Displaying all articles
The United States Preventive Services Task Force, the Canadian Cancer Society and several Canadian provinces now endorse breast cancer screening for women ages 40-49, but the new guidelines from the Canadian Task Force on Preventive Health Care do not. (Shutterstock)

Ignoring reason and evidence: Why new breast cancer guidelines advising against screening women in their 40s are misguided

Anna N. Wilkinson, L’Université d’Ottawa/University of Ottawa; Jean Seely, L’Université d’Ottawa/University of Ottawa; Moira Rushton, L’Université d’Ottawa/University of Ottawa, and Suleena Duhaime, L’Université d’Ottawa/University of Ottawa

Early detection is crucial in the fight against breast cancer. Yet the Canadian Task Force on Preventive Health Care’s new guidelines do not endorse breast cancer screening for women in their 40s.
Breast density is one of the factors that can influence whether people should pursue supplemental screening. andresr/E+ via Getty Images

The FDA’s rule change requiring providers to inform women about breast density could lead to a flurry of questions

Wendie A. Berg, University of Pittsburgh

Dense breast tissue is common and normal, but it can make cancer more difficult to detect. FDA requirements going into effect in September 2024 will dictate that patients be better informed about it.

Related Topics

  1. Artificial intelligence (AI)
  2. Breast cancer
  3. Breast cancer screening
  4. Food and Drug Administration (FDA)
  5. Mammography
  6. MRI
  7. radiologists
  8. Radiology
  9. Ultrasound
  10. Women's health

Top contributors

More